IMU 1.82% 5.6¢ imugene limited

Check-vacc - possible complete response case study!, page-51

  1. 273 Posts.
    lightbulb Created with Sketch. 385
    Hi Dave,
    Thanks for your well wishes. No she is no longer on the trial, I think normally once they see progression they decide that you shouldn't continue (although that didnt seem to happen with the Bile Duct Cancer patient who had a CR thankfully!!). Believe it or not she is now on Enhertu, the same drug mentioned in your checkvacc study posted above so who knows...........maybe in a little while we will see a similar result? Heres hoping.

    As Reon said they haven't released any Breast cancer results yet but maybe we'll see some good results down the line in that indication. I think its fair to say there is absolutely no doubt now that CF33 is having some good effects and of course it still has a way to run. There's not only higher doses to come but it will also branch out into combinations, with Keytruda but also CD19 targeted therapies that hopefully increase its effectiveness.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.6¢
Change
0.001(1.82%)
Mkt cap ! $411.5M
Open High Low Value Volume
5.5¢ 5.7¢ 5.3¢ $731.7K 13.32M

Buyers (Bids)

No. Vol. Price($)
5 580359 5.6¢
 

Sellers (Offers)

Price($) Vol. No.
5.7¢ 686331 5
View Market Depth
Last trade - 16.10pm 18/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.